Search results for "Blood Pressure"

showing 10 items of 1254 documents

Hyperuricemia and non-dipping blood pressure

2013

Dear editor The strong association between the metabolic derangements that characterize the metabolic syndrome with arterial hypertension is very well-known, as it is the common finding of hyperuricemia in the patients with the metabolic syndrome. Besides, hyperuricemia has been found to be associated with cardiovascular, renal, and metabolic diseases; including not only gout but also type 2 diabetes mellitus, although its role as a risk factor is still debated.1 We were not aware of previous studies describing an association between uric acid levels and the non-dipping 24-hour blood pressure (BP) pattern, and for that reason we were intrigued by Tutal et al’s article, regarding hypertensiv…

medicine.medical_specialtyLetterInternational Journal of Nephrology and Renovascular Disease03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicineHyperuricemiasleep apnea blood pressure uric acidbusiness.industrymedicine.disease3. Good healthGoutObstructive sleep apneaEndocrinologyBlood pressure030228 respiratory systemchemistryNephrologyUric acidMetabolic syndromebusinessHypopnea030217 neurology & neurosurgeryDyslipidemiaInternational Journal of Nephrology and Renovascular Disease
researchProduct

Hemodynamic changes following injection of local anesthetics with different concentrations of epinephrine during simple tooth extraction: A prospecti…

2015

Background Presence of epinephrine in local anesthetic cartridge increases the duration of local anesthesia (LA), decreases the risk of toxicity, and provides hemostasis. However, the unfavorable effects are increasing heart rate (HR) and raising blood pressure (BP). The aim was to evaluate hemodynamic changes in the BP, HR, and oxygen saturation (SpO2) of normal patients undergoing tooth extraction using LA with various epinephrine concentrations. Material and Methods A prospective randomized clinical trial was conducted on 120 patients who were divided randomly into 3 parallel groups according to the LA received. Group 1: lidocaine 2% with epinephrine 1:80,000 (L80). Group 2: articaine 4%…

medicine.medical_specialtyLidocaineLocal anestheticmedicine.drug_classbusiness.industryResearchHemodynamicsOdontologíaArticaine:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryBlood pressureEpinephrineAnesthesiaHeart rateUNESCO::CIENCIAS MÉDICASmedicineLocal anesthesiaOral SurgerybusinessGeneral Dentistrymedicine.drugJournal of Clinical and Experimental Dentistry
researchProduct

Bowel resection reduces aortic pulse wave velocity in patients with ulcerative colitis. A longitudinal study.

2020

NA

medicine.medical_specialtyLongitudinal studySettore MED/09 - Medicina Internamedicine.medical_treatmentInflammationBlood PressurePulse Wave AnalysisInflammatory bowel diseaseGastroenterologyInflammatory bowel diseaseVascular StiffnessInternal medicineInternal MedicinemedicineHumansIn patientLongitudinal StudiesPulse wave velocityArterial stiffness Inflammation Inflammatory bowel disease Pulse wave velocity Blood Flow Velocity Blood Pressure Humans Longitudinal Studies Pulse Wave Analysis Colitis Ulcerative Vascular StiffnessInflammationbusiness.industryBowel resectionmedicine.diseaseUlcerative colitisArterial stiffnessPulse wave velocityArterial stiffnessColitis Ulcerativemedicine.symptombusinessBlood Flow VelocityEuropean journal of internal medicine
researchProduct

Echocardiography in assessing acute pulmonary hypertension due to pulmonary embolism.

1980

Eighteen patients with acute pulmonary embolism were studied with right heart catheterization and M mode echocardiography. No patient had evidence of preexisting cardiopulmonary disease; pulmonary embolism was documented with pulmonary angiography. The mean pulmonary arterial pressure correlated with the angiographic severity index of embolic obstruction (r = 0.61, p 2 , p 2 ) and in 5 patients with acute pulmonary embolism and a mean normal pulmonary arterial pressure (10.9 ± 0.4 mm/m 2 ). For all measurements the index size of the right pulmonary artery correlated with the mean pulmonary arterial pressure (r = 0.84, p

medicine.medical_specialtyM Mode Echocardiographybusiness.industryHeart VentriclesHypertension PulmonaryBlood PressurePulmonary arterial pressureMiddle AgedPulmonary Arterymedicine.diseaseRight pulmonary arteryPulmonary hypertensionPulmonary embolismEchocardiographyInternal medicineAcute DiseasePulmonary angiographyCardiologyMedicineHumansCardiology and Cardiovascular MedicinebusinessPulmonary wedge pressurePulmonary EmbolismCardiopulmonary diseaseThe American journal of cardiology
researchProduct

The nephroprotective effect of sacubitril/valsartan in heart failure: insights from the real-life clinical setting

2019

Real-life data confirming the favourable renal outcome in patients with heart failure (HF) treated with Sacubitril/Valsartan, previously found in several trials (RCTs), are still scant. We evaluated the renal effects of Sacubitril/Valsartan in a real-life sample of HF patients. Observational analysis of 54 consecutive outpatients affected by HF with reduced ejection fraction (HFrEF) and clinical indication for Sacubitril/Valsartan. Patients were evaluated at baseline (T0) and after six (T6) and twelve (T12) months after initiating Sacubitril/Valsartan and compared with a group of 30 historical controls. Mean age: 65.5 ± 11.7 years. Older patients: 29 (53.7%). Mean baseline estimated glomeru…

medicine.medical_specialtyMEDLINETetrazolesHeart failureLifeInternal MedicinemedicineHumansKidney dysfunctionSacubitril-ValsartanIntensive care medicinebusiness.industryAminobutyratesBiphenyl CompoundsFollow up studiesSacubitril/Valsartanmedicine.diseaseIm - OriginalDrug CombinationsValsartanHeart failureBlood pressureEmergency MedicineValsartanbusinessSacubitril ValsartanFollow-Up StudiesRenal functionmedicine.drug
researchProduct

Relationship between metabolic syndrome and aortic stiffness in untreated hypertensive patients

2005

medicine.medical_specialtyMean arterial pressureAmbulatory blood pressurebusiness.industrymedicine.diseaseBlood pressureDiabetes mellitusInternal medicineHeart rateInternal MedicinemedicineCardiologyAortic stiffnessMetabolic syndromebusinessPulse wave velocityAmerican Journal of Hypertension
researchProduct

Hemodynamic effects of dobutamine in children with cardiovascular failure.

1982

The effect of dobutamine, a synthetic catecholamine, was studied in 12 patients aged one day to 14 years with low cardiac output syndromes. After initial stabilization of the patients dobutamine was administered by continuous infusion in a dosage of 7.5 or 10 μg/kg/min. Heart rate, cardiac output (using thermodilution technique and/or pulse contour method), mean systemic and mean pulmonary artery pressures were determined before and after the dobutamine infusion. Systemic and pulmonary vascular resistances, cardiac index and stroke volume index were calculated. Cardiac output and cardiac index increased significantly in every patient, whereas the heart rate changed only slightly, suggesting…

medicine.medical_specialtyMean arterial pressureCardiac outputAdolescentCardiac indexHemodynamicsBlood PressurePulmonary ArteryCatecholaminesHeart RateInternal medicinemedicine.arteryDobutamineHeart ratemedicineHumansCardiac OutputChildHeart Failurebusiness.industryHemodynamicsInfant NewbornInfantStroke VolumeStroke volumeAnesthesiaPediatrics Perinatology and Child HealthPulmonary arteryCardiologyDobutamineVascular Resistancebusinessmedicine.drugEuropean journal of pediatrics
researchProduct

The effect of exercise training on blood pressure in menopause and postmenopausal women: A systematic review of randomized controlled trials

2021

The prevalence of hypertension is higher in postmenopausal than in premenopausal women. Regular exercise training has been shown to be effective in addressing hypertension. The aim of this systematic review was to synthesize the effect of exercise training on systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP) in menopausal and postmenopausal women. This review was reported according to the PRISMA statement and registered in PROSPERO. The literature search was done in MEDLINE, Embase, Cochrane CENTRAL and ClinicalTrials. Randomized controlled trials involving menopausal and postmenopausal women undergoing exercise training were included. Two blinde…

medicine.medical_specialtyMean arterial pressureeducationPopulationMEDLINEBlood PressureGeneral Biochemistry Genetics and Molecular BiologyPrehypertensionlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicinemedicineHumansAerobic exercise030212 general & internal medicineeducationExerciseRandomized Controlled Trials as Topiceducation.field_of_study030219 obstetrics & reproductive medicinebusiness.industryObstetrics and Gynecologymedicine.diseaseMenopauseBlood pressureHypertensionFemaleMenopausebusinessMaturitas
researchProduct

Sodium-glucose cotransporter 2 inhibition : towards an indication to treat diabetic kidney disease

2020

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have clearly demonstrated their beneficial effect in diabetic kidney disease (DKD) on top of the standard of care [blood glucose control, renin–angiotensin system blockade, smoking cessation and blood pressure (BP) control], even in patients with overt DKD. However, the indication of this drug class is still blood glucose lowering in type 2 diabetic patients with estimated glomerular filtration rate >45mL/min/1.73m2. Based on the new evidence, several scientific societies have emphasized the preferential prescription of SGLT2i for patients at risk of heart failure or kidney disease, but still within the limits set by health authorities. A r…

medicine.medical_specialtyMedicina030232 urology & nephrologyRenal functionReviewsType 2 diabetes030204 cardiovascular system & hematologyDiabetic nephropathy03 medical and health sciences0302 clinical medicineSodium-Glucose Transporter 2Internal medicineDiabetes mellitusDiabetic nephropathiesmedicineChronic renal failureHumansDiabetic NephropathiesDiabetic kidney diseaseESRDSodium-Glucose Transporter 2 InhibitorsTransplantationbusiness.industryType 2 diabetesNefropaties diabètiquesmedicine.diseasePrognosisBlood pressureDiabetes Mellitus Type 2NephrologyHeart failureSodium/Glucose Cotransporter 2Insuficiència renal crònicabusinessSGLT2 inhibitorsKidney disease
researchProduct

In vivo antihypertensive mechanism of lactoferrin-derived peptides: Reversion of angiotensin I- and angiotensin II-induced hypertension in Wistar rats

2015

Novel peptides with antihypertensive effects in SHR rats have previously been identified in lactoferrin (LF) hydrolysates. To investigate their in vivo antihypertensive mechanism, we have assessed the blood pressure lowering effects of two of these LF-derived peptides (RPYL and DPYKLRP) in Wistar rats subjected to either angiotensin I- or angiotensin II-induced hypertension. Blood pressure was measured by the tail-cuff method, hypertension was induced by subcutaneous infusion of angiotensins, and then captopril, valsartan or LF-derived peptides orally administered. Angiotensin I- and angiotensin II-induced hypertension were reversed by captopril and valsartan, respectively. RPYL and DPYKLRP…

medicine.medical_specialtyMedicine (miscellaneous)Lactoferrin-derived peptidesPharmacologyWistar ratAntihypertensive peptidesInternal medicineRenin–angiotensin systemMedicineTX341-641Angiotensin-induced hypertensionNutrition and DieteticsAngiotensin II receptor type 1biologyNutrition. Foods and food supplybusiness.industryCaptoprilAngiotensin-converting enzymeAngiotensin IIBlood pressureEndocrinologyValsartanbiology.proteinRenin angiotensin systemmedicine.symptombusinessVasoconstrictionFood Sciencemedicine.drugIn vivo ACE inhibition
researchProduct